Immune reconstitution
| . | . | At last assessment . | . | |||
|---|---|---|---|---|---|---|
| <2 y post-HSCT∗ . | ≥2 y post-HSCT† . | |||||
| Time to last assessment | Median (IQR) | 4.8 mo (2.4-12.3) | 60.9 mo (42-91.5) | |||
| Missing (%) | ‡N (%)∗ | Missing (%) | ‡N (%)∗ | |||
| Total | 104 (100) | 225 (100) | ||||
| IgRT | No | 44 (42.3) | 23 (38.3) | 9 (4) | 185 (85.6) | |
| Yes | 22 (36.7) | 25 (11.6) | ||||
| Not evaluated | 8 (13.3) | 2 (0.9) | ||||
| Unknown | 7 (11.7) | 4 (1.9) | ||||
| Missing (%) | Median (IQR) | Missing (%) | Median (IQR) | Normal range† | ||
| Lymphocytes (109/L) | 66 (63.5) | 1.1 (0.6-2.2) | 50 (22.2) | 2.0 (1.3-3.2) | 1.00-4.80 | |
| CD3+ T-cells (109/L) | 79 (76) | 0.8 (0.3-1.6) | 107 (47.6) | 1.2 (0.7-2.0) | 0.79-2.01 | |
| CD4+ T-cells (109/L) | 81 (77.9) | 0.2 (0.1-0.5) | 104 (46.2) | 0.6 (0.4-1.2) | 0.45-1.25 | |
| CD8+ T-cells (109/L) | 81 (77.9) | 0.5 (0.2-0.6) | 104 (46.2) | 0.6 (0.3-1.5) | 0.22-0.69 | |
| CD56+ NK-cells (109/L) | 81 (77.9) | 0.2 (0.1-0.3) | 113 (50.2) | 0.2 (0.1-3.1) | 0.10-0.44 | |
| CD19+ B-cells (109/L) | 81 (77.9) | 0 (0-0.3) | 118 (52.4) | 0.4 (0.2-1.1) | 0.11-0.36 | |
| Naïve T cells (109/L) | 96 (92.3) | 0 (0-0.1) | 177 (78.7) | 0.5 (0.2-1.5) | 0.19-0.98 | |
| . | . | At last assessment . | . | |||
|---|---|---|---|---|---|---|
| <2 y post-HSCT∗ . | ≥2 y post-HSCT† . | |||||
| Time to last assessment | Median (IQR) | 4.8 mo (2.4-12.3) | 60.9 mo (42-91.5) | |||
| Missing (%) | ‡N (%)∗ | Missing (%) | ‡N (%)∗ | |||
| Total | 104 (100) | 225 (100) | ||||
| IgRT | No | 44 (42.3) | 23 (38.3) | 9 (4) | 185 (85.6) | |
| Yes | 22 (36.7) | 25 (11.6) | ||||
| Not evaluated | 8 (13.3) | 2 (0.9) | ||||
| Unknown | 7 (11.7) | 4 (1.9) | ||||
| Missing (%) | Median (IQR) | Missing (%) | Median (IQR) | Normal range† | ||
| Lymphocytes (109/L) | 66 (63.5) | 1.1 (0.6-2.2) | 50 (22.2) | 2.0 (1.3-3.2) | 1.00-4.80 | |
| CD3+ T-cells (109/L) | 79 (76) | 0.8 (0.3-1.6) | 107 (47.6) | 1.2 (0.7-2.0) | 0.79-2.01 | |
| CD4+ T-cells (109/L) | 81 (77.9) | 0.2 (0.1-0.5) | 104 (46.2) | 0.6 (0.4-1.2) | 0.45-1.25 | |
| CD8+ T-cells (109/L) | 81 (77.9) | 0.5 (0.2-0.6) | 104 (46.2) | 0.6 (0.3-1.5) | 0.22-0.69 | |
| CD56+ NK-cells (109/L) | 81 (77.9) | 0.2 (0.1-0.3) | 113 (50.2) | 0.2 (0.1-3.1) | 0.10-0.44 | |
| CD19+ B-cells (109/L) | 81 (77.9) | 0 (0-0.3) | 118 (52.4) | 0.4 (0.2-1.1) | 0.11-0.36 | |
| Naïve T cells (109/L) | 96 (92.3) | 0 (0-0.1) | 177 (78.7) | 0.5 (0.2-1.5) | 0.19-0.98 | |